Longwood Healthcare Leaders Fall Webconference

September 21 - 22, 2022

The Longwood Healthcare Leaders Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients.

Registered participants are invited to join a cocktail party at the Brookline Country Club, site of the 2022 US Open Golf Championship.

Featured Speakers

 
 

Fall Webconference Agenda

​These meetings are off-the-record and focused on accelerating the translation of discoveries into medicines to help patients; substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities. 

9:20 am ET

EARLY PREPARATION FOR PARTNERING

Jennifer Cayer, CBO, Pulmocide

Matthias Müllenbeck, SVP, Head, Global BD & Alliance Management, Merck KGaA

Alban de La Sabliere, SVP, Global Head, Partnering, Sanofi

1:00 pm ET

EXPEDITING RESEARCH FOR TREATMENTS AND CURES

Bill Hait, Global Head, External Innovation, Johnson & Johnson
Saul Kato, CEO, Herophilus

10:20 am ET

George Daley, Dean, Harvard Medical School

Moderator: Christoph Westphal, General Partner, Longwood Fund

FIRESIDE CHAT

10:40 am ET

Stewart Campbell, CEO, Axial Therapeutics

Sandra Glucksmann, CEO, Cedilla Therapeutics

Rick Morgan, CSO, Be Bio

THE NEXT WAVE OF TARGETED THERAPIES

11:10 am ET

R&D COLLABORATION

Raquel Mura, Head, R&D, North America, Sanofi

Rupert Vessey, President, Research & Early Development, Bristol Myers Squibb

11:40 am ET

REGULATORY & INDUSTRY ROUNDTABLE

Peter Marks, Director, CBER, FDA

12:30 pm ET

SOURCING AND IDENTIFYING NOVEL TECHNOLOGY

Larry Hamann, CEO, Interdict Bio

Reenie McCarthy, CEO, Stealth BioTherapeutics

9:50 am ET

CREATING A WORLD WITHOUT DISEASE

Mike Devoy, CMO, Bayer
Reed Jobs, Managing Director, Health, Emerson Collective

Peter Lebowitz, SVP & Head, Global Oncology, Janssen

1:30 pm ET

FIRESIDE CHAT

Hal Barron, CSO & President, R&D, GlaxoSmithKline

Mathai Mammen, Global Head, R&D, Janssen Pharmaceuticals

1:50 pm ET

DESIGNING THE DEAL

Heather Schwoebel, COO & CBO, Alloy Therapeutics

Joanne Smith-Farrell, CEO, Be Bio

Bob Silverman, CBO, Rejuveron

2:20 pm ET

DRUG DISCOVERY SCIENCES

Iris Grossman, CSO, Eleven Therapeutics

Stefen Laukien, CEO, Retroviral Therapeutics

3:40 pm ET

EXTERNAL INNOVATION

Henry Gosebruch, Chief Strategy Officer, AbbVie

Mary Lynne Hedley, Senior Fellow, Broad Institute, MIT

Moderator: Chandra Ramanathan, EIR, Mass General Brigham

4:10 pm ET

VENTURE INVESTING: DEVELOPING THE SYNDICATE

4:40 pm ET

LONGWOOD FUND UPDATE 

Lizzie Ngo, Senior Associate, Longwood Fund

2:50 pm ET

ACCELERATING THE PATH TO PATIENT CARE

Jennifer Buell, CEO, MiNK

Kabir Nath, CEO, Otsuka US
David Weinreich, EVP, Head, Global Clinical Development, Regeneron

3:20 pm ET

FIRESIDE CHAT

John Reed, EVP, Global Head, R&D, Sanofi

7:00 am ET

LONGWOOD FUND INTRODUCTION

Christoph Westphal, General Partner, Longwood Fund

7:30 am ET

MOVING BEYOND NEWCO

Philip Astley-Sparke, CEO, Replimune

Jim Scibetta, CEO, ImmuneID

8:00 am ET

George Scangos, CEO, Vir Bio
Christophe Weber, CEO, Takeda

FIRESIDE CHAT

8:20 am ET

BIG BIOPHARMA PIPELINE SOURCING

Jim List, Global Therapeutic Head Cardiovascular, Metabolism, & Retina, Janssen
Christian Rommel, EVP & Head, R&D, Bayer Pharmaceuticals

8:50 am ET

INSTITUTION SPOTLIGHT: HARVARD MED

Wednesday, September 21, 2022

12:00 pm ET

SCIENTIFIC INNOVATION: LAUNCHING COMPANIES FROM ACADEMIA

Phil Johnson, CEO, Interius BioTherapeutics
Lloyd Minor, Dean, Stanford School of Medicine
Kai Wucherpfennig, Chair, Cancer Immunology & Virology, Dana-Farber Cancer Institute

10:40 am ET

ADVANCING PLATFORM TECHNOLOGIES

Annalisa D’Andrea, President & CSO, ImmuneID

Pearl Huang¸ CEO, Cygnal Therapeutics

8:50 am ET

ACCELERATING DRUG DEVELOPMENT

Christian Antoni, Chief Development Officer, EQRx

Paulo Fontoura, Global Head & SVP Rare Diseases, Roche

James Sapirstein, CEO, First Wave BioPharma

10:20 am ET

FIRESIDE CHAT

Ed Markey, Senator, Commonwealth of Massachusetts

11:40 am ET

FIRESIDE CHAT

Merdad Parsey, EVP & CMO, Gilead
George Yancopoulos, President & CSO, Regeneron

12:00 pm ET

MAINTAINING MOMENTUM POST-IPO

Ivana Magovcevic-Liebish, CEO, Vigil Neuroscience

Stuart Peltz, CEO, PTC Bio

12:30 pm ET

INNOVATIVE PARTNERSHIPS

Jason Kelly, CEO, Ginkgo Bioworks

Patrick Verheyen, Global Head, BD, Janssen

1:00 pm ET

NOVEL THERAPEUTIC MODALITIES

Chad May, CSO, Serotiny

Chris Thanos, CEO, Actym Therapeutics

Moderator: Michal Preminger, Regional Head, Johnson & Johnson Innovation, East North America

1:30 pm ET

FIRESIDE CHAT

Mikael Dolsten, CSO & President, Worldwide Research, Development and Medical, Pfizer

Phil Sharp, Co-Founder, Biogen/Alnylam

2:20 pm ET

MOVING FROM DATA TO MEDICINE

Kara Carter, EIR, Evotec

Anne Heatherington, R&D Chief Data and Technology Officer, Takeda
Paul Schimmel, Professor, Cell & Molecular Biology, Scripps

2:50 pm ET

FIRESIDE CHAT

Bob Langer, Academic Founder, Moderna; Institute Professor, MIT

3:50 pm ET

APPROACHES TO REGULATORY HURDLES

Dietmar Berger, CMO, Global Head of Development, Sanofi

Stewart Geary, CMO, Eisai

Raymond Sanchez, CMO, Cerevel Therapeutics

11:10 am ET

CLINICAL TRIAL EFFICIENCY

Kathy High, President, Therapeutics, AskBio

Oliver Rosen, President & CMO, Dynamicure

7:30 am ET

HARNESSING BIOMEDICAL INNOVATION

Krishnan Viswanadhan, President & COO, Be Bio

Greg Verdine, CEO, Fog Pharmaceuticals 

Moderator: Manuel Aivado, CEO, Aileron

7:00 am ET

LONGWOOD FUND INTRODUCTION

David Steinberg, General Partner, Longwood Fund

8:00 am ET

FIRESIDE CHAT

Christophe Weber, CEO, Takeda

9:20 am ET

PREPARING FOR THE FUTURE OF R&D

Ruxandra Draghia-Akli, Global Head, Global Public Health R&D, Janssen
Frank Nestle, Global Head of Research & CSO, Sanofi

Al Sandrock, CEO, Voyager Therapeutics

9:50 am ET

INNOVATION IN RNA TECHNOLOGY

Kathy Fernando, Head, mRNA Scientific Strategy & Head, WWRD & Medical Operations, Pfizer

Kevin Fitzgerald, CSO, Alnylam

4:40 pm ET

LONGWOOD FUND UPDATE 

Lucy Liu, Senior Associate, Longwood Fund

1:50 pm ET

RECRUITING TALENT, DEVELOPING CULTURE

Alisha Alaimo, President, US, Biogen

Roger Tung, CEO, Concert Pharmaceuticals

8:20 am ET

GLOBAL MARKETS: WORKING ACROSS BORDERS

Ken Keller, CEO, Global Head, Oncology, Daiichi Sankyo Inc.
Paul Perreault, CEO, CSL

Thursday, September 22, 2022

3:20 pm ET

FIRESIDE CHAT

George Scangos, CEO, Vir Bio

4:20 pm ET

EVOLVING INVESTMENT TRENDS 

Ansbert Gadicke, Managing Director, MPM Capital

Matthias Kleinz, SVP, Translational Science, UPMC Enterprises

Registered participants are invited to join a cocktail party at the Brookline Country Club, site of the 2022 US Open Golf Championship at the close of the meeting on September 22nd in Brookline, MA.

Thursday, September 22, 2022

 
 
 
alexandria-logo-1-300x200.png

​To learn more about getting involved contact sg@longwoodfund.com

Supporters 

SUN__Logo_Tag_Web_color.png